Cite
Master protocols in immuno-oncology: do novel drugs deserve novel designs?
MLA
Mazzarella, Luca, et al. “Master Protocols in Immuno-Oncology: Do Novel Drugs Deserve Novel Designs?” Journal for Immunotherapy of Cancer, vol. 8, no. 1, Mar. 2020. EBSCOhost, https://doi.org/10.1136/jitc-2019-000475.
APA
Mazzarella, L., Morganti, S., Marra, A., Trapani, D., Tini, G., Pelicci, P., & Curigliano, G. (2020). Master protocols in immuno-oncology: do novel drugs deserve novel designs? Journal for Immunotherapy of Cancer, 8(1). https://doi.org/10.1136/jitc-2019-000475
Chicago
Mazzarella, Luca, Stefania Morganti, Antonio Marra, Dario Trapani, Giulia Tini, Piergiuseppe Pelicci, and Giuseppe Curigliano. 2020. “Master Protocols in Immuno-Oncology: Do Novel Drugs Deserve Novel Designs?” Journal for Immunotherapy of Cancer 8 (1). doi:10.1136/jitc-2019-000475.